Anesthesia in patients with neuromuscular disorders

Minerva Anestesiologica

Volumn 75, Issue 11, 2009, Pages 632-637

  Schmitt, H J ^a   Muenster, T ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

Anesthesia; Anesthetics; Central; Muscle relaxants; Neuromuscular diseases; Perioperative care

Indexed keywords

ANESTHETIC AGENT; AUTOANTIBODY; CARDIOVASCULAR AGENT; INHALATION ANESTHETIC AGENT; MUSCLE RELAXANT AGENT; NITROUS OXIDE; PROPOFOL; SUXAMETHONIUM; THIOPENTAL;

AMYOTROPHIC LATERAL SCLEROSIS; ANESTHESIA; ANESTHESIA COMPLICATION; ANESTHESIST; CHROMOSOME XP; DUCHENNE MUSCULAR DYSTROPHY; EATON LAMBERT SYNDROME; FRIEDREICH ATAXIA; HEREDITARY MOTOR SENSORY NEUROPATHY; HUMAN; HYPERKALEMIA; INTRAVENOUS ANESTHESIA; LUNG FUNCTION TEST; MALIGNANT HYPERTHERMIA; MOTOR NEURON DISEASE; MUSCLE ATROPHY; MUSCLE WEAKNESS; MYASTHENIA GRAVIS; MYOTONIC DYSTROPHY; NEUROMUSCULAR DISEASE; NEUROPATHY; NOTE; PERIPHERAL NEUROPATHY; POSTOPERATIVE PERIOD; REGIONAL ANESTHESIA; RESPIRATORY FAILURE; SKELETAL MUSCLE; SPINAL MUSCULAR ATROPHY;

ANESTHESIA; HUMANS; NEUROMUSCULAR DISEASES; RISK FACTORS;

EID: 72449149178     PISSN: 03759393     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Note

References (40)

1. Breucking E, Reimnitz P, Schara U, Mortier W. [Anesthetic complications. The incidence of severe anaesthetic complications in patients and families with progressive muscular dystrophy of the Duchenne and Becker types]. Anaesthesist 2000;49:187-195
2. Klingler W, Lehmann-Horn F, Jurkat-Rott K. Complications of anaesthesia in neuromuscular disorders. Neuromuscul Disord 2005;15:195-206.
3. Rowland LP, Shneider NA. Amyotrophic lateral sclerosis. N Engl J Med 2001;344:1688-1700
4. Boillee S, Vande Velde C, Cleveland DW. ALS: a disease of motor neurons and their nonneuronal neighbors. Neuron 2006;52:39-59. (Pubitemid 44466358)
5. Jablonka S, Sendtner M. Molecular and cellular basis of spinal muscular atrophy. Amyotroph Lateral Scler Other Motor Neuron Disord 2003;4:144-149 (Pubitemid 37184882)
6. Bach JR, Niranjan V, Weaver B. Spinal muscular atrophy type 1: A noninvasive respiratory management approach. Chest 2000;117:1100-1105 (Pubitemid 30228371)
7. Cavadini P, O'Neill HA, Benada O, Isaya G. Assembly and iron-binding properties of human frataxin, the protein deficient in Friedreich ataxia. Hum Mol Genet 2002;11:217-227 (Pubitemid 34173351)
8. Weidemann F, Eyskens B, Mertens L, Di Salvo G, Strotmann J, Buyse G et al. Quantification of regional right and left ventricular function by ultrasonic strain rate and strain indexes in Friedreich's ataxia. Am J Cardiol 2003;91:622-626 (Pubitemid 36263274)
9. Martyn JA, White DA, Gronert GA, Jaffe RS, Ward JM. Up-and-down regulation of skeletal muscle acetylcholine receptors. Effects on neuromuscular blockers. Anesthesiology 1992;76:822-843
10. Habib AS, Helsley SE, Millar S, Deballi P, 3rd, Muir HA. Anesthesia for cesarean section in a patient with spinal muscular atrophy. J Clin Anesth 2004;16:217-219 (Pubitemid 38813273)
11. Mouloudi H, Katsanoulas C, Frantzeskos G. Requirements for muscle relaxation in Friedreich's ataxia. Anaesthesia 1998;53:177-180 (Pubitemid 28052366)
12. Schmitt HJ, Wick S, Munster T. Rocuronium for muscle relaxation in two children with Friedreich's ataxia. Br J Anaesth 2004;92:592-596 (Pubitemid 38443866)
13. Harris SJ, Moaz K. Caesarean section conducted under sub-arachnoid block in two sisters with spinal muscular atrophy. Int J Obstet Anesth 2002;11:125-127 (Pubitemid 34563729)
14. Campbell AM, Finley GA. Anaesthesia for a patient with Friedreich's ataxia and cardiomyopathy. Can J Anaesth 1989;36:89-93. (Pubitemid 19042889)
15. Berciano J, Combarros O. Hereditary neuropathies. Curr Opin Neurol 2003;16:613-622
16. Rudnik-Schoneborn S, Rohrig D, Nicholson G, Zerres K. Pregnancy and delivery in Charcot-Marie-Tooth disease type 1. Neurology 1993;43:2011-2016 (Pubitemid 23318870)
17. Ducart A, Adnet P, Renaud B, Riou B, Krivosic-Horber R. Malignant hyperthermia during sevoflurane administration. Anesth Analg 1995;80:609-618
18. Antognini JF. Anaesthesia for Charcot-Marie-Tooth disease. a review of 86 cases. Can J Anaesth 1992;39:398-400.
19. Kotani N, Hirota K, Anzawa N, Takamura K, Sakai T, Matsuki A. Motor and sensory disability has a strong relationship to induction dose of thiopental in patients with the hypertropic variety of Charcot-Marie-Tooth syndrome. Anesth Analg 1996;82:182-186 (Pubitemid 126448322)
20. Schmitt HJ, Munster T. Mivacurium-induced neuromuscular block in adult patients suffering from Charcot-Marie-Tooth disease. Can J Anaesth 2006;53:984-988 (Pubitemid 44822784)
21. Lindstrom JM. Acetylcholine receptors and myasthenia. Muscle Nerve 2000;23:453-477
22. Grob D, Brunner N, Namba T, Pagala M. Lifetime course of myasthenia gravis. Muscle Nerve 2008;37:141-149
23. Mahadeva B, Phillips LH, 2nd, Juel VC. Autoimmune disorders of neuromuscular transmission. Semin Neurol 2008;28:212-227
24. Vanlinthout LE, Robertson EN, Booij LH. Response to suxamethonium during propofol-fentanyl-N2O/O2 anaesthesia in a patient with active myasthenia gravis receiving long-term anticholinesterase therapy. Anaesthesia 1994;49:509-511
25. De Haes A, Proost JH, Kuks JB, van den Tol DC, Wierda JM. Pharmacokinetic/pharmacodynamic modeling of rocuronium in myasthenic patients is improved by taking into account the number of unbound acetylcholine receptors. Anesth Analg 2002;95:588-596 (Pubitemid 35006848)
26. Mann R, Blobner M, Jelen-Esselborn S, Busley R, Werner C. Preanesthetic train-of-four fade predicts the atracurium requirement of myasthenia gravis patients. Anesthesiology 2000;93:346-350 (Pubitemid 30620307)
27. Nitahara K, Sugi Y, Higa K, Shono S, Hamada T. Neuromuscular effects of sevoflurane in myasthenia gravis patients. Br J Anaesth 2007;98:337-341 (Pubitemid 47072671)
28. Blobner M, Mann R. Anesthesia in patients with myasthenia gravis. Anaesthesist 2001;50:484-493
29. Finsterer J, Stollberger C. Cardiac involvement in primary myopathies. Cardiology 2000;94:1-11.
30. Muntoni F, Torelli S, Ferlini A. Dystrophin and mutations: one gene, several proteins, multiple phenotypes. Lancet Neurol 2003;2:731-740 (Pubitemid 37443515)
31. Jacobson C, Cote PD, Rossi SG, Rotundo RL, Carbonetto S. The dystroglycan complex is necessary for stabilization of acetylcholine receptor clusters at neuromuscular junctions and formation of the synaptic basement membrane. J Cell Biol 2001;152:435-450 (Pubitemid 34280229)
32. Machuca-Tzili L, Brook D, Hilton-Jones D. Clinical and molecular aspects of the myotonic dystrophies: a review. Muscle Nerve 2005;32:1-18. (Pubitemid 40917885)
33. Zifko UA, Hahn AF, Remtulla H, George CF, Wihlidal W, Bolton CF. Central and peripheral respiratory electrophysiological studies in myotonic dystrophy. Brain 1996;119:1911-1922 (Pubitemid 27032623)
34. Hayes J, Veyckemans F, Bissonnette B. Duchenne muscular dystrophy: an old anesthesia problem revisited. Paediatr Anaesth 2008;18:100-106
35. Wick S, Muenster T, Schmidt J, Forst J, Schmitt HJ. Onset and duration of rocuronium-induced neuromuscular blockade in patients with Duchenne muscular dystrophy. Anesthesiology 2005;102:915-919 (Pubitemid 40586531)
36. Mitchell MM, Ali HH, Savarese JJ. Myotonia and neuromuscular blocking agents. Anesthesiology 1978;49:44-48
37. White RJ, Bass SP. Myotonic dystrophy and paediatric anaesthesia. Paediatr Anaesth 2003;13:94-102.
38. Mathieu J, Allard P, Gobeil G, Girard M, De Braekeleer M, Begin P. Anesthetic and surgical complications in 219 cases of myotonic dystrophy. Neurology 1997;49:1646-1650 (Pubitemid 28015132)
39. Aquilina A, Groves J. A combined technique utilising regional anaesthesia and target-controlled sedation in a patient with myotonic dystrophy. Anaesthesia 2002;57:385-386 (Pubitemid 34279463)
40. Wu S, Ibarra MC, Malicdan MC, Murayama K, Ichihara Y, Kikuchi H et al. Central core disease is due to RYR1 mutations in more than 90% of patients. Brain 2006;129: 1470-1480 (Pubitemid 43999380)